ABEO — Abeona Therapeutics Share News
0.000.00%
Last trade - 00:00- $260.76m
- $128.92m
- $5.82m
Abeona Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: Abeona Therapeutics And Beacon Therapeutics Announce Non-Exclusive Agreement For Beacon To Evaluate Therapeutic Potential Of Abeona's Patented AAV204 Capsid For Select Ophthalmology Indications
Abeona Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Abeona Therapeutics Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Amazon.com, American Express, Mattel
Abeona slumps after FDA declines approval for its skin disorder treatment
US FDA declines to approve Abeona's skin disorder treatment (updated)
US FDA declines to approve Abeona's skin disorder treatment
Brief: Abeona Therapeutics Provides Regulatory Update On Pz-cel
Brief: Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Abeona Therapeutics Announces Progress Update On Pz-Cel Biologics License Application (BLA)
U.S. STOCKS ON THE MOVE-DR Horton, Federal Realty, RedHill Biopharma
U.S. STOCKS ON THE MOVE-Affirm, Lucid, Domino's Pizza
Abeona rises after US FDA priority review nod for epidermolysis bullosa
Brief: FDA Grants Priority Review For Abeona Therapeutics' Pz-cel Biologics License Application
Brief: Abeona Therapeutics Q3 EPS USD -0.48
U.S. STOCKS ON THE MOVE-Vera Bradley, Apple, Salesforce
U.S. STOCKS ON THE MOVE-Energy firms, Gold miners, Tingo group